The Accelerated Biased Coin Up-and-Down Design in Phase I Trials
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2004 |
|---|---|
| Erschienen: |
2004 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Journal of biopharmaceutical statistics - 14(2004), 1, Seite 249 |
| Beteiligte Personen: |
Stylianou, Mario [VerfasserIn] |
|---|
| BKL: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1659809053 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1659809053 | ||
| 003 | DE-627 | ||
| 005 | 20230518001518.0 | ||
| 007 | tu | ||
| 008 | 040316s2004 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw040316 |
| 035 | |a (DE-627)OLC1659809053 | ||
| 035 | |a (DE-599)GBVOLC1659809053 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 570 |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Stylianou, Mario |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Accelerated Biased Coin Up-and-Down Design in Phase I Trials |
| 264 | 1 | |c 2004 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Follmann, Dean A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of biopharmaceutical statistics |d Philadelphia, Pa. : Taylor & Francis, 1991 |g 14(2004), 1, Seite 249 |w (DE-627)170952770 |w (DE-600)1131763-2 |w (DE-576)313955867 |x 1054-3406 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2004 |g number:1 |g pages:249 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 14 |j 2004 |e 1 |h 249 | ||